STOCK TITAN

Vertex (NASDAQ: VRTX) director receives new equity grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Vertex Pharmaceuticals director Nancy Thornberry reported routine equity compensation changes. On May 1, 2026, she disposed of 398 shares of common stock back to the issuer in exchange for 398 deferred stock units under a deferred compensation plan, leaving 2,109 common shares at that step.

She then acquired 472 additional common shares as a grant, increasing her direct common stock holdings to 2,507 shares. Thornberry also received 398 deferred stock units, each linked to one share of common stock and payable upon specified future events, and a fully vested stock option for 1,433 shares with a $424.45 exercise price expiring on April 30, 2036.

Positive

  • None.

Negative

  • None.
Insider Thornberry Nancy
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 1,433 $0.00 --
Grant/Award Deferred Stock Units 398 $0.00 --
Grant/Award Common Stock 472 $0.00 --
Disposition Common Stock 398 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 1,433 shares (Direct, null); Deferred Stock Units — 398 shares (Direct, null); Common Stock — 2,507 shares (Direct, null)
Footnotes (1)
  1. Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Upon the vesting of restricted stock units granted to Ms. Thornberry on May 1, 2025, Ms. Thornberry deferred the receipt of 398 shares of common stock and received instead 398 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. Thornberry is reporting the disposition of 398 shares of common stock in exchange for an equal number of deferred stock units. Fully vested. Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. Thornberry's service on our board of directors, (ii) a change of control of our company and (iii) Ms. Thornberry's disability or death.
Shares disposed to issuer 398 shares Common stock exchanged for deferred stock units on May 1, 2026
Common shares granted 472 shares Grant increased direct holdings to 2,507 shares
Deferred stock units granted 398 units Each unit represents one share of common stock
Stock options granted 1,433 options Stock Option (Right to Buy) on May 1, 2026
Option exercise price $424.45 per share Exercise price for 1,433 stock options, expiring April 30, 2036
Shares after disposition step 2,109 shares Common shares directly held after 398-share disposition
Shares after grants 2,507 shares Direct common stock holdings following 472-share grant
Restricted stock unit financial
"Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
deferred stock units financial
"deferred the receipt of 398 shares of common stock and received instead 398 deferred stock units pursuant to our deferred compensation plan."
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
deferred compensation plan financial
"received instead 398 deferred stock units pursuant to our deferred compensation plan."
A deferred compensation plan is an arrangement where an employer agrees to pay part of an employee’s pay or bonus at a later date instead of immediately, often to reduce current tax bills or to tie rewards to long-term performance. For investors it matters because these promises create future cash obligations and influence executive incentives and retention; they can affect a company’s reported liabilities, cash flow planning and the risk profile if the business faces financial trouble.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 424.4500 and expiration on 2036-04-30."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Thornberry Nancy

(Last)(First)(Middle)
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE

(Street)
BOSTON MASSACHUSETTS 02210

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
VERTEX PHARMACEUTICALS INC / MA [ VRTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/01/2026A472(1)A$02,507D
Common Stock05/01/2026D398D(2)2,109D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$424.4505/01/2026A1,433 (3)04/30/2036Common Stock1,433$01,433D
Deferred Stock Units(4)05/01/2026A398 (4) (4)Common Stock398(2)398D
Explanation of Responses:
1. Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
2. Upon the vesting of restricted stock units granted to Ms. Thornberry on May 1, 2025, Ms. Thornberry deferred the receipt of 398 shares of common stock and received instead 398 deferred stock units pursuant to our deferred compensation plan. As a result, Ms. Thornberry is reporting the disposition of 398 shares of common stock in exchange for an equal number of deferred stock units.
3. Fully vested.
4. Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Ms. Thornberry's service on our board of directors, (ii) a change of control of our company and (iii) Ms. Thornberry's disability or death.
Remarks:
/s/ Christiana Stevenson, Attorney-in-Fact05/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Vertex (VRTX) director Nancy Thornberry report in this Form 4?

Nancy Thornberry reported routine equity compensation activity at Vertex. She exchanged 398 common shares for 398 deferred stock units, received 472 common shares as a grant, and was awarded stock options and additional deferred stock units as part of her director compensation.

How many Vertex (VRTX) common shares does Nancy Thornberry hold after these transactions?

After the reported transactions, Nancy Thornberry directly holds 2,507 shares of Vertex common stock. This reflects a grant of 472 shares following a 398-share disposition tied to deferral, as shown by the post-transaction share balances disclosed in the filing.

What stock options did Nancy Thornberry receive from Vertex (VRTX)?

Nancy Thornberry received a fully vested stock option covering 1,433 shares of Vertex common stock at an exercise price of $424.45 per share. The option expires on April 30, 2036, giving her a long-dated right to buy shares at that price.

What are the deferred stock units reported by Nancy Thornberry at Vertex (VRTX)?

Thornberry received 398 deferred stock units, each representing one share of Vertex common stock. These units will be paid out in common stock upon the earliest of her board service termination, a company change of control, or her disability or death, according to the disclosure.

Was Nancy Thornberry’s Vertex (VRTX) Form 4 a market buy or sell of shares?

The Form 4 does not show open-market buys or sells. Instead, it records a disposition of 398 shares back to the issuer in exchange for deferred stock units and grants of common stock, deferred stock units, and stock options as compensation-related awards.